JAMA Neurology Data Shows Meaningful Effects With Biogen's QALSODY In Long-Term Results
(RTTNews) - Biogen Inc. (BIIB) said The Journal of the American Medical Association (JAMA) Neurology has published final results from the completed Phase 3 VALOR study and its open-label extension study OLE that evaluates QALSODY or tofersen for the …